The story of copyright's flagship drug presents a interesting case for investors in the medicinal sector. While initially a blockbuster success, creating vast sums, the intellectual property expiration and the https://pharma042401.blogs100.com/42161745/the-little-copyright-and-pharma-a-hazardous-investment